TAYLOR THRASH: Open Payments
NPI 1871158121 · MURRELLS INLET, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 49 payments from 18 companies in 2025. Trend: 2023 $1,138 · 2024 $1,310 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $223 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| ABBVIE INC. | 4 | $71 |
| Alkermes, Inc. | 2 | $56 |
| Exact Sciences Corporation | 3 | $53 |
| Braeburn Inc. | 2 | $49 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
| Abbott Laboratories | 2 | $46 |
| Lilly USA, LLC | 3 | $42 |
Products named: TRELEGY ELLIPTA, Wegovy, Ozempic, FARXIGA, VIVITROL, VRAYLAR, Cologuard Collection Kit, BRIXADI.
Industry payments across SC — which companies pay providers there.
